Duality Advisers, LP Teva Pharmaceutical Industries LTD Transaction History

Duality Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$8.12 - $10.63 $1.26 Million - $1.65 Million	155,267 New	155,267 $1.62 Million
Q2 2023 Jul 31, 2023	BUY	$7.2 - $9.47 $150,415 - $197,837	20,891 Added 7.08%	316,056 $2.38 Million
Q1 2023 Jun 27, 2023	BUY	$8.36 - $11.37 $2.47 Million - $3.36 Million	295,165 New	295,165 $2.61 Million
Q3 2022 Nov 03, 2022	SELL	$6.86 - $11.95 $189,466 - $330,047	-27,619 Reduced 7.31%	350,417 $2.83 Million
Q2 2022 Aug 08, 2022	BUY	$7.38 - $10.4 $2.79 Million - $3.93 Million	378,036 New	378,036 $2.84 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.